F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
D

Psychotropic Medication Monitoring and Indication Not Adequately Documented

Spring Grove Rehabilitation And Healthcare CenterNew Providence, New Jersey Survey Completed on 03-30-2026

Summary

The facility failed to adequately monitor target behavior for psychotropic medications and failed to ensure that an antianxiety medication was ordered for an appropriate diagnosis or indication for one resident reviewed for unnecessary medications. The resident was admitted with diagnoses including COPD, muscle weakness, difficulty walking, and need for assistance with personal care. The March 2026 eMAR showed orders for duloxetine 30 mg daily for depression, trazodone 50 mg at bedtime for insomnia, and clonazepam 0.5 mg every 14 hours PRN for insomnia/anxiety. The record contained no behavior monitoring documented for duloxetine, trazodone, or clonazepam during March. The resident’s most recent cMDS showed a BIMS score of 13/15, indicating intact cognition, and reflected receipt of an antianxiety and antidepressant medication, but did not identify an active diagnosis for those medications. The care plan included focus areas for antianxiety medication use and depression/anxiety related to admission to the nursing facility, with interventions to administer medications as ordered and monitor/document side effects and effectiveness, but it did not document target behaviors for the psychotropic medications. The late entry H&P and physician progress notes documented COPD and anxiety/depression, but there was no documented indication for insomnia in the progress notes. A psychiatric DNP note listed clinical signs and target symptoms of anxiety and depression and included clonazepam, duloxetine, melatonin, and trazodone as psychotropic medications being monitored. During interview, the LPN/UM stated that diagnosis and indication should be based on physician documentation and confirmed behavior monitoring should be in the eMAR, while the DON later stated the clonazepam order was clarified and behavior monitoring was entered after the surveyor’s inquiry.

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Resources

Below are regulatory guidelines relevant to this citation:

See other F0605 citations
PRN Antipsychotic Order Not Limited or Reassessed
D
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

PRN Antipsychotic Order Not Limited or Reassessed: A resident with advanced dementia, Alzheimer’s disease, agitation, and hospice services received PRN haloperidol for agitation and delirium under an open-ended order rather than a 14-day limit. Physician documentation continued the medication but did not show an evaluation of its ongoing need or an adequate rationale for renewal, and nursing notes did not document non-pharmacological interventions before one PRN dose was given.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Lack of Behavior Monitoring for Antipsychotic Use
D
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

A resident with depression and delusional disorders was prescribed Olanzapine for delusions, but the MAR and care plan showed no targeted behavior monitoring or other behavioral documentation to support the medication’s use or effectiveness. The SS Director and DNS both confirmed the resident was not on behavior monitoring, despite the facility stating residents on antipsychotics were placed on it.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Antipsychotic Use Lacked Documented Diagnosis Support
D
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

A resident with severe dementia and behavioral symptoms received Seroquel with multiple dose increases, but the orders did not include a documented diagnosis to justify use or escalation. The chart showed dementia, agitation, and later psychosis documentation, while staff described the resident as generally directable and pleasant with more evening behaviors. The resident also had falls during the stay, including one that led to ER transfer.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
PRN Lorazepam Lacked Required Stop Date and Rationale
D
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

A resident with anxiety, restlessness, agitation, and moderately impaired cognition received PRN lorazepam for anxiety, but the order had no stop date and the EHR lacked a documented duration with physician rationale for continued use. The psychotropic care plan did not address the PRN lorazepam, and an RN verified the facility had not obtained the required 14-day stop date or documentation for ongoing use.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Incomplete Psychotropic Behavior Monitoring and Orthostatic BP Documentation
D
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

Incomplete Psychotropic Monitoring Documentation: The facility did not complete or accurately document monthly behavior summaries for a resident receiving Ativan, quetiapine, risperidone, and sertraline, and another resident’s behavior summary for lurasidone HCl and fluoxetine HCl was inaccurate compared with the MAR. The same resident also lacked complete orthostatic BP monitoring documentation, as the required sitting readings were not recorded within the appropriate time frame. The SSD and DON verified the missing and incorrect documentation.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Psychotropic Medication Consent and GDR Documentation Failure
E
F0605 F605: Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Short Summary

A resident with CVA and dementia, and severe cognitive impairment, received trazodone for depression without a completed medication consent form before the medication was administered. The record also showed a pharmacist-recommended GDR was declined with documentation that family routinely declines GDRs, but the rationale did not state that a further dose reduction would likely impair function or cause psychiatric instability, as required.

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.
Citation search

Search every citation & Plan of Correction

Go to search
Citation watch

Track new serious citations across New Jersey

Get a heads-up on the newest immediate-jeopardy (J–L) citations in New Jersey — where surveyors are focused right now.

Free · about one email a month

Trusted data from CMS and state health departments

Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release October 8, 2026) and official state health department websites — never guesswork.

In your survey window? See what surveyors are citing.

The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.

Get the Survey-Prep Report
An unhandled error has occurred. Reload 🗙

Connection lost — reconnecting… We couldn't reconnect automatically. Please reload the page to continue.